In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome

International Journal of Pharmaceutics

Volumn 203, Issue 1-2, 2000, Pages 61-69

  Junping, Wang ^a   Maitani, Yoshie ^a   Takayama, Kozo ^a   Nagai, Tsuneji ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Anticancer action; Biodistribution; Doxorubicin; Long circulation; Pharmacokinetics; Proliposome; Remote loading

Indexed keywords

DOXORUBICIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; CONTROLLED STUDY; DRUG DISTRIBUTION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG CARRIERS; LIPOSOMES; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; TISSUE DISTRIBUTION;

EID: 0034255532     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00410-5     Document Type: Article

References (16)

1. Batzri S., Korn E.D. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta. 298:1973;1015-1019.
2. Cox S.K., Wilke A.V., Frazier D. Determination of adrimycin in plasma and tiisue biospices. J. Chromatogr. 564(1):1991;322-329.
3. Fossen E.A., Tokes Z.A. In vitro and in vivo studies with adrimycin liposomes. Biochem. Biophys. Res. Commun. 91(4):1979;1295.
4. Lee H.J., Ahn B., Paik W.H., Shim C., Lee M.J. Inverse targeting of reticuloendothelial system-rich organs after intravenous admistration of adriamycin-loaded neutral proliposomes containing poloxamer 407 to rats. Int. J. Pharm. 131:1996;91-96.
5. Paney N.I., Browning I., Hynes C.A. Characterization of proliposome. J. Pharm. Sci. 75:1986a;330-333.
6. Paney N.I., Timmis P., Ambrose C.V., Warel M.D., Ridway F. Proliposomes: a novel solution to an old problem. J. Pharm. Sci. 75:1986b;325-329.
7. Katare O.P., Vyas S.P., Dixit V.K. Proliposomes on indomethacin for oral administration. J. Microencap. 8:1991a;295-300.
8. Katare O.P., Vyas S.P., Dixit V.K. Preperation and performance evaluation of pain proliposomal systems for cytoprotections. J. Microencap. 8:1991b;295-300.
9. Rahman A., Carmichael D., Harris M., Rohr J.K. Comparirive Pharmacokinetics of free doxorubicin antrapped in cardiolipin liposomes. Cancer Res. 46:1986a;2295-2299.
10. Rahman A., Fumagalli A., Barbieri B., Schein P.S., Casazza A.M. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Chemother. Pharmacol. 16(1):1986b;22-27.
11. Rahman A., White G., more N., Schein P.S. Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. Cancer Res. 44:1985;5427-5432.
12. Vaage J., Donovan D., Uster P., Working P. Tumor uptake of doxorubicin in polyethylene-glyco coated liposomes and therapeutic effect againsta xenografted human pancreatic carcinoma. Br. J. Cancer. 75:1997;482-488.
13. Wang J.P., Su D.S., Gu X.Q. Studies on adriamycin proliposome prepared by spray drying method. Chinese Pharm. J. 3:1994;149-151.
14. Working P.K., Newman M.S., Huang S.K. et al. Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in Stealth® liposomes (Doxil®). J. Liposome Res. 4:1994;667-687.
15. Wu N.Z., Da D., Ruddoll T.L., Needaham D., Whorton R., Dewhirst M.W. Increased microvascular permeability contributes to preferential accumulation of STEALTH liposomes in tumor tissue. Cancer Res. 53:1993;3765-3770.
16. Yamaoka K., Tanigawara Y., Nakagaa T., Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4(11):1981;879-885.